DOCSLIB.ORG

Japan Myanmar Association Members List <Regular Member> 1. Marubeni Corporation. 2. Mitsubishi Corporation. 3. Nippon Ko

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Japan Myanmar Association Members List <Regular Member> 1. Marubeni Corporation. 2. Mitsubishi Corporation. 3. Nippon Ko Japan Myanmar Association Members List <Regular Member> 1. Marubeni Corporation. 2. Mitsubishi Corporation. 3. Nippon Koei Co., Ltd. 4. Hitachi, Ltd. 5. Oriental Consultants Co., Ltd. 6. Electric Power Development Co., Ltd. (J-Power) 7. Nikken Sekkei Civil Engineering Ltd. 8. Taiyo Life Insurance Company 9. Konishiyasu Co., Ltd. 10. Otsuka Pharmaceutical Factory, Inc. 11. Taisei Construction Co., Ltd. 12. Nissin Corporation 13. Sumitomo Corporation 14. Mitsui & Co., Ltd. 15. The Bank of Tokyo-Mitsubishi UFJ, Ltd. 16. Chiyoda Corporation. 17. All Nippon Airways Co., Ltd. 18. Life Corporation Co., Ltd. 19. Seishin Kosan Co., Ltd. 20. Lawson, Inc. 21. Posco Japan Co.,. Ltd. 22. Aeon Group 23. Musashi-Fusoh, Co., Ltd. 24. Mitsubishi Motors Corporation 25. Metal One Corporation 26. Arix Co. Ltd. 27. Asia Air Survey Co., Ltd. 28. Hazama Ando Corporation 29. Japan Myanmar Cultural, Economic, Friendship Association 30. Ise Foods, Inc. 31. Kokyo Tatemono Co., Ltd. 32. JFE Steel Corporation 33. NEC Corporation 34. Marubeni-Itochu Steel Inc. 35. Nippon Telegraph and Telephone Corporation (NTT) 36. Mitsubishi Heavy Industries, Ltd. 37. JX Nippon Oil & Gas Exploration Corporation 38. Itochu Corporation 39. Sonpo Japan Nipponkoa Insurance Inc. 40. Sumitomo Mitsui Banking Corporation 41. Tokio Marine & Nichido Fire Insurance Co., Ltd. 42. Foundation for Global Children 43. Isuzu Motors Limited 44. TMI Associates 45. Mitsubishi Materials Corporation 46. CHUBU Electric Power Co., Ltd. 47. Mori Hamada & Matsumoto 48. JX Nippon Oil & Energy Corporation 49. Nippon Meat Packers, Inc. 50. Mitsubishi Electric Corporation 51. Daiwa Institute of Research Ltd. 52. Ryobi Holdings Co., Ltd. 53. Takashimaya Co., Ltd. 54. Yoshimoto Pole Co., Ltd. 55. Nippon Suisan Kaisha, Ltd. 56. Osaka Sanitary Co., Ltd. 57. Nagashima Ohno & Tsunematsu 58. CBS Corporation 59. Suzuki Motor Corporation 60. Anderson Mori & Tomotsune 61. Toshiba Corporation 62. Nippon Express Co., Ltd. 63. Japan Exchange Group, Inc. 64. Nippon Steel & Sumitomo Metal Corporation 65. Naigai Trans Line Ltd. 66. Secom Co., Ltd. 67. Mitsubishi UFJ Lease & Finance Co., Ltd. 68. Idemitsu Kosan Co., Ltd. 69. Toyota Tsusho Corporation 70. Meidensha Corporation 71. Eastern Car Liner, Ltd. 72. KPMG AZSA LLC 73. IHI Infrastructure System Co., Ltd. 74. IHI Corporation 75. Rio Co., Ltd. 76. IHI Transport Machinery Co., Ltd. 77. Mizuho Bank, Ltd. 78. Daiwa Living Co, Ltd. 79. Suzue Corporation 80. Ams International Co., Ltd. 81. Kirin Holdings Co., Ltd. 82. DS Health Care Group (Dental Support Co., Ltd.) 83. Shinko Corporation 84. Educational Institution Tokyo Business Gakuen 85. JTB Corporate Sales Inc. 86. Dentsu Sports Asia, Pte. Ltd. 87. JCB International Co,. Ltd. 88. Big Thumb Co., Ltd. 89. KDDI Corporation 90. ARD Japan Co., Ltd. 91. Aichi Electric Co., Ltd. 92. FUJITRANS Corporation 93. ROHTO Pharmaceutical Co., Ltd. 94. CTI Engineering Co., Lte. 95. Hitachi Zosen Corporation 96. Spaaqs Asset Management Co., Ltd. 97. Asia Total Law Office 98. Asia Legal Research and Finance Co., Ltd. 99. JGC Corporation 100. Sumitomo Chemical Co., Ltd. 101. Taikisha Ltd. 102. Sumitomo Osaka Cement Co., Ltd. 103. Hongo Tsuji Tax & Consulting 104. Fuji Television Network, Inc. 105. NTT DATA Corporation 106. NTT Communications Corporation 107. NTT DOCOMO Inc. 108. Sumitomo Bakelite Co., Ltd. 109. Sumitomo Heavy Industries, Ltd. 110. Sumitomo Forestry Co., Ltd. 111. The Overseas Coastal Area Development Institute of Japan 112. Japan Asia Strategic Advisory 113. Tokuoka Sekkei LTD. 114. Japan Dredging and Reclamation Engineering Association 115. Sojitz Corporation 116. Fujitsu Ltd. 117. Wakachiku Construction Co., Ltd. 118. Osaka Gas Co., Ltd. 119. Yanmar Co., Ltd. 120. Co., Ltd. Hozenall 121. Nagata Co., Ltd. 122. Tomio Sekiyu Co., Ltd. 123. Sumitomo Mitsui Construction Co., Ltd. 124. Mitsui Sumitomo Insurance Co., Ltd. 125. Penta-Ocean Construction Co., Ltd. 126. MIRAIT Technologies Corporation 127. Toyo Business Engineering Corporation 128. Yangon International Hotel Japan 129. M-Tamai Architects & Associates 130. Fujita Corporation 131. JFE Shoji Trade Corporation 132. Starts Corporation Co., Ltd. 133. Sohgo Security Services Co., Ltd. 134. Kygnus Sekiyu K.K. 135. Asean Human Resource Development Cooperative 136. Shindo Express Co., Ltd. 137. Ichibiki Co., Ltd. 138. Yakult Honsha Co., Ltd. 139. Kawasaki Kisen Kaisha, Ltd. 140. Miki-Sigen Co., ltd. 141. Fujiwork Co., Ltd. 142. Next Creation Inc. 143. Rajah & Tann Singapore LLP 144. Myanmar Japan Thilawa Development Ltd. 145. Myanmar Japon Co., Ltd. <Supporting Member> 1. Joy Tec Inc. 2. Apex International Inc. 3. Nepro Japan Co., Ltd. 4. Anzu Corporation 5. Vessel Hotel Development Co., Ltd. 6. General Institute of Psychology Co., Ltd. 7. Asahi Sangyo Kaisha, Ltd. 8. Sunrise Co-op. 9. Shinra Network Co., Ltd. 10. Lami Corporation Inc. 11. Daiyukai Health System .
Load more

Recommended publications
  • Nilotinib in Patients with Chronic Myeloid Leukemia: STAT2 Trial in Japan
    Haematologica HAEMATOL/2018/194894 Version 3 Haematologica HAEMATOL/2018/194894 Version 3 Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan Naoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, Nobuyuki Aotsuka, Koji Sano, Chikako Ohwada, Jun Kuroki, Hideo Kimura, Michihide Tokuhira, Kinuko Mitani, Kazuhisa Fujikawa, Osamu Iwase, Kohshi Ohishi, Fumihiko Kimura, Tetsuya Fukuda, Sakae Tanosaki, Saori Takahashi, Yoshihiro Kameoka, Hiroyoshi Nishikawa, and Hisashi Wakita Disclosures: 1. This study was supported by research funding from Novartis Pharmaceuticals to N.T. 2. N.T reports grants from Novartis Pharmaceuticals, during the conduct of the study; grants and personal fees from Novartis Pharmaceuticals, grants and personal fees from Otsuka, grants and personal fees from Pfizer, personal fees from Bristol-Myers Squibb, outside the submitted work; K.N reports grants from Zenyaku Kogyo Company, Limited, grants from Chugai Pharmaceutical, grants from Novartis Pharma K.K., grants from Kyowa Hakko Kirin Co, Ltd, grants from Nippon Shinyaku Co, Ltd, outside the submitted work; C.N reports personal fees from Novartis, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Pfizer, grants and personal fees from Takeda pharmaceuticals, grants and personal fees from Kyowa Hakko Kirin, grants and personal fees from Otsuka Pharmaceutical, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Chugai Pharmaceutical, grants and personal fees from Asahi Kasei Pharma, grants and personal fees from Shionogi, personal fees from Shire, personal fees from Jannsen, personal fees from Celgene, outside the submitted work; M.T. reports personal fees from Bristol-Myers Squib, personal fees from Pfizer, outside the submitted work; K.M reports grants from Kyowa Hakko Kirin Co.
    [Show full text]
  • OCTOBER 2020 PTAB Public Hearing Schedule
    OCTOBER 2020 PTAB Public Hearing Schedule Proceeding No. Serial No. PARTY Date Time 2020-004197 16043641 BIOGEN MA INC Thursday, October 1, 2020 9:00 AM (EDT) ALLERGAN PHARMACEUTICALS 2020-002635 13907447 Thursday, October 1, 2020 9:00 AM (EDT) INTERNATIONAL LIMITED 2020-002276 13612925 BAYER AG (MONSANTO) Thursday, October 1, 2020 9:00 AM (EDT) 2020-002277 13612929 OTSUKA PHARMACEUTICAL CO., 2020-002304 14341306 Thursday, October 1, 2020 9:00 AM (EDT) LTD. 2020-002327 15893354 CELLECTIS Thursday, October 1, 2020 9:00 AM (EDT) 2020-000258 15163285 POLY GROUP LLC Thursday, October 1, 2020 9:00 AM (PDT) 2020-000640 15414456 DISCERNDX INC. Thursday, October 1, 2020 9:00 AM (PDT) 2020-000934 13982470 DENOVO BIOMARKERS INC. Thursday, October 1, 2020 9:00 AM (PDT) THE BOARD OF TRUSTEES OF THE 2020-001247 15175848 LELAND STANFORD JUNIOR Thursday, October 1, 2020 9:00 AM (PDT) UNIVERSITY EDWARDS LIFESCIENCES 2020-001487 14563866 Thursday, October 1, 2020 9:00 AM (PDT) CORPORATION IKEDA FOOD RESEARCH COL LTD 2020-003630 16145178 Thursday, October 1, 2020 1:00 PM (EDT) and PHC CORPORATION 2020-002049 13310632 ADARE PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-000053 13135898 OLEG ILLICH EPSHTEIN Thursday, October 1, 2020 1:00 PM (EDT) 2020-001829 15008646 MERZ PHARMA GMBH & CO. KGAA Thursday, October 1, 2020 1:00 PM (EDT) 2020-002360 15407037 IONIS PHARMACEUTICALS INC. Thursday, October 1, 2020 1:00 PM (EDT) 2020-002113 13729631 L'OREAL Thursday, October 1, 2020 1:00 PM (EDT) 2019-003658 13576565 QUNZHU LI and LI LI Thursday, October 1, 2020 1:00 PM (EDT) 2020-000322 14136660 CYTEC INDUSTRIES INC.
    [Show full text]
  • Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA
    Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT
    [Show full text]
  • Sumitomo Chemical Estimate Total Approx
    Create New Value Change and Innovation Create New Value MorganStanley MUFG Chemicals Conference December 19, 2017 1- 1 - Create New Value Contents Create New Value Performance Trends 3-9 Business Strategy 10-16 Business Strategy by Sector 17-51 Initiatives for Maintaining 52-61 Sustained Growth Conclusion 62-64 2- 2 - Performance Trends 3 Create New Value FY2017 1H vs. FY2016 1H (Billions of yen) FY2016 FY2017 1H 1H Change Sales 900.5 1,054.1 +153.6 Operating Income 47.3 92.0 +44.8 (Equity in Earnings of Affiliates) 18.8 22.6 +3.8 Ordinary Income 50.6 115.0 +64.4 Net Income Attributable to Owners of the Parents 19.2 68.5 +49.3 Naphtha Price ¥31,500/kl ¥37,600/kl Exchange Rate ¥105.20/$ ¥111.04/$ 4 Create New Value FY2017 1H vs. FY2016 1H: Operating Income by Sector (Billions of yen) FY2016 FY2017 Change Reason for Change 1H 1H Specialty Chemicals 45.4 72.5 +27.2 Energy & Functional Increased shipment volumes Materials 2.2 9.9 +7.7 of resorcinol and SEP Increased shipment volumes IT-related Chemicals 2.5 8.7 +6.2 of polarizing films and touchscreen panels Lower methionine market Health & Crop Sciences 12.9 5.6 -7.2 prices Pharmaceuticals 27.9 48.3 +20.5 Increased sales of Latuda Bulk Chemicals 6.7 25.0 +18.3 Petrochemicals & Improved margins of MMA Plastics 6.7 25.0 +18.3 and synthetic resins Others -4.8 -5.5 -0.8 Total 47.3 92.0 +44.8 5 Create New Value FY2017 Forecast vs.
    [Show full text]
  • OSB Participant List by Research Area
    OSB Participant List by Research Area Contact Centers (CC) • AARP • Air Products and • American Drug Stores Chemicals • AAA • ABB • American Electric Power • Airbus • Accor • Abbott • American Express • Alcatel Lucent • American Electric Power • Abengoa • American International • Alcoa Group • American International • Abu Dhabi National Group Energy Company • Alcon • American Stores Company • Austin Energy • ACC Limited • Alfa • American Water • Bank of America • Access Insurance Holdings • Algonquin Power & • Amgen Utilities • Blue Cross Blue Shield • Accord Holdings • AMIL • ALH Group • Charles Schwab & • ACE • AmInvestment Bank Company • Alitalia • Acea • AMR • Citigroup • ALK Abello • Acer • Amssi • Citizens Gas • Alkermes • Acxiom • Amtran Logistics • Clarke American • Allergan • Adelaide Clinic Holdings • Andrew Corporation • CPS Energy • Alliance & Leicester • Adidas • Anglian Water Services • Direct Energy • Alliance Boots • Advance Food Company • Anritsu • Federal Reserve Bank of • Alliant Techsystems Minneapolis • Advance Publications • Anschutz • Allianz • John Deere • Advanced Coating • Apache • Allied Irish Banks • Technologies Louisville Water Company • Apex Equity Holdings • Advanced Semiconductor • Allstate Insurance • Manila Electric Company Engineering Company • Apple • • • Mellon Financial Adventist Health System Ally Financial • Arcadia Housing • • • MetLife Aegon Alon USA Energy • Arcos Dorados Holdings • • • Morgan Stanley AEON AlpTransit Gotthard • Ardent Health Services • • • NetBank Aera Energy Alstom • Argos •
    [Show full text]
  • Table of Contents/AFLAC's Mission
    Table of Contents Message From Management . 2 Selected Financial Data . 32 1999 marked the 10th consecutive year in which AFLAC Summary statements of earnings and balance sheets, stock Incorporated achieved its earnings objective. AFLAC Japan price ranges, price/earnings ratios and exchange rates for and AFLAC U.S. both contributed to make 1999 another the past 11 years. record year. Consolidated Financial Statements . 34 Interview With the CEO . 6 Statements of earnings, shareholders’ equity, cash flows, President and CEO Dan Amos discusses the importance of comprehensive income and balance sheets for AFLAC earnings objectives, deregulation in Japan and the market Incorporated and subsidiaries. for supplemental insurance. Notes to the Consolidated Financial Statements . 38 AFLAC Japan . 8 Additional information about the company’s Consolidated Despite a difficult economy, AFLAC Japan produced record Financial Statements and accounting policies. sales, increased its distribution system and continued preparation for a deregulated market. Glossary . 57 Definitions of terms used by AFLAC and the insurance AFLAC U.S.. 14 industry. AFLAC U.S. had its best year ever, with revenues, pretax operating earnings and new sales growing rapidly and Investor Information . 58 reaching record levels in 1999. AFLAC’s shares significantly outperformed other insurance stocks, although they did not keep up with the market as a Management’s Discussion and Analysis . 19 whole in 1999. An overview of AFLAC’s financial and operational performance in Japan and the United States during the last Directors and Management . 60 three years and an analysis of the company’s overall Biographical information on the company’s leadership. financial condition.
    [Show full text]
  • Takashimaya / 8233
    Takashimaya / 8233 COVERAGE INITIATED ON: 2012.06.21 LAST UPDATE: 2020.12.25 Shared Research Inc. has produced this report by request from the company discussed in the report. The aim is to provide an “owner’s manual” to investors. We at Shared Research Inc. make every effort to provide an accurate, objective, and neutral analysis. In order to highlight any biases, we clearly attribute our data and findings. We will always present opinions from company management as such. Our views are ours where stated. We do not try to convince or influence, only inform. We appreciate your suggestions and feedback. Write to us at [email protected] or find us on Bloomberg. Research Coverage Report by Shared Research Inc. Takashimaya / 8233 RCoverage LAST UPDATE: 2020.12.25 Research Coverage Report by Shared Research Inc. | www.sharedresearch.jp INDEX How to read a Shared Research report: This report begins with the trends and outlook section, which discusses the company’s most recent earnings. First-time readers should start at the business section later in the report. Executive summary ----------------------------------------------------------------------------------------------------------------------------------- 3 Key financial data ------------------------------------------------------------------------------------------------------------------------------------- 5 Recent updates ---------------------------------------------------------------------------------------------------------------------------------------- 6 Highlights ------------------------------------------------------------------------------------------------------------------------------------------------------------
    [Show full text]
  • ANNUAL REPORT FY2014 for the Year Ended March 31, 2015 Courtesy of Mizushima LNG Co., Ltd
    ANNUAL REPORT FY2014 For the year ended March 31, 2015 Courtesy of Mizushima LNG Co., Ltd. Financial Highlights Years Ended March 31, 2015, 2014, 2013, 2012, and 2011 2015 2014 2013 2012 2011 For the Year (Millions of Yen) Revenues ¥480,979 ¥446,147 ¥398,918 ¥254,675 ¥247,082 Cost of revenue 435,327 404,685 356,402 215,783 215,563 Operating income 21,466 21,079 25,113 24,197 17,544 Income before income taxes and minority interests 22,012 22,538 26,747 23,543 11,476 Net income 11,029 13,447 16,077 14,364 7,979 At Year-End (Millions of Yen) Total assets ¥515,839 ¥475,288 ¥435,379 ¥365,795 ¥353,392 Profile Total equity 208,405 198,031 189,356 168,737 155,758 Current ratio (%) 151.0 156.3 166.3 165.5 173.8 Founded in 1948 in the post war period to reconstruct Japan, Chiyoda started its engi- Per Common Share (Yen) neering business for domestic projects mainly in petroleum refining, gas processing and Earnings per share (EPS) ¥42.58 ¥51.91 ¥62.06 ¥55.44 ¥30.79 petrochemical fields, and expanded into overseas projects in the 1960s. Since then, Chiyoda Book value per share (BPS) 796.89 758.31 727.24 648.95 599.15 has been and is growing steadily under the corporate philosophy of enhancing its business by aiming for harmony between energy and the environment and contributing to the Dividend per share 13.0 16.0 19.0 17.0 11.0 sustainable development of society.
    [Show full text]
  • Sumitomo Chemical 100 Years Sumitomo Chemical 100 Years Published: August 2014 Published by Sumitomo Chemical Co.,Ltd
    Sumitomo Chemical 100 Years Sumitomo Chemical 100 Years Published: August 2014 Published by Sumitomo Chemical Co.,Ltd. Production and editing : Sumitomo Chemical Co.,Ltd., Corporate History Editorial Office 27-1, Shinkawa 2-chome, Chuo-ku, Tokyo, Japan Production assisted by Dai Nippon Printing Co.,Ltd. Printed in Japan by Dai Nippon Printing Co.,Ltd. CONTENTS Chairman’s Message President’s Message The Path to a Global Chemical Company 1. The History of Sumitomo 8 2. History of Sumitomo Fertilizer Works 10 3. Going from a Fertilizer Manufacturer to a Chemical Company 14 4. Moving into Fine Chemicals 16 5. Post-war Recovery 18 6. Moving into the Agricultural Chemicals Business 20 7. Growth of the Pharmaceuticals Sector 22 8. Entering the Field of Petrochemicals 24 9. Dealing with the Oil Crises 26 10. Rise and Decline of Aluminum Business 28 11. Construction of Singapore Petrochemical Complex 32 12. Separation of Pharmaceutical Business from Sumitomo Chemical and Inauguration 34 of Dainippon Sumitomo Pharma Co., Ltd. 13. Expansion of Agricultural Chemicals Business 36 14. IT-related Chemicals Sector Established and Business Grows 38 15. Progress of the Rabigh Project 40 16. Aiming to be a Truly Global Chemical Company 42 17. For a Better Tomorrow 46 Reports from Regional Headquarters 48 Report from Beijing by Sumitomo Chemical (China) Co., Ltd. 48 Report from Singapore by Sumitomo Chemical (Asia Pacific) Pte Ltd 50 Report from Brussels by Sumitomo Chemical Europe S.A./N.V. 52 Report from New York by Sumitomo Chemical America, Inc. 54 The Sumitomo Spirit and Sumitomo Chemical’s Business Philosophy 56 Recent Sales and Profits 57 Sumitomo Chemical Locations in Japan 58 Major Companies of Sumitomo Chemical Group: Japan 59 Major Companies of Sumitomo Chemical Group: International 60 Chronology of Sumitomo Chemical 62 Chairman’s Message In October 2015, Sumitomo Chemical will cele- triggered by the fall of Lehman Brothers and the sub- brate its 100 year anniversary.
    [Show full text]
  • Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 21LADY
    Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 Board Lot Stock Name (in Alphabetical Order) ＩＳＩＮ Code ＱＵＩＣＫ Code Size 21LADY CO.,LTD. 100 JP3560550000 3346 3-D MATRIX,LTD. 100 JP3410730000 7777 4CS HOLDINGS CO.,LTD. 100 JP3163300001 3726 A DOT CO.,LTD 100 JP3160590000 7063 A-ONE SEIMITSU INC. 100 JP3160660001 6156 A.D.WORKS GROUP CO.,LTD. 100 JP3160560003 2982 A&A MATERIAL CORPORATION 100 JP3119800005 5391 A&D COMPANY,LIMITED 100 JP3160130005 7745 A&T CORPORATION 100 JP3160680009 6722 ABALANCE CORPORATION 100 JP3969530009 3856 ABC-MART,INC. 100 JP3152740001 2670 ABHOTEL CO.,LTD. 100 JP3160610006 6565 ABIST CO.,LTD. 100 JP3122480001 6087 ACCESS CO.,LTD. 100 JP3108060009 4813 ACCESS GROUP HOLDINGS CO.,LTD. 100 JP3108190004 7042 ACCRETE INC. 100 JP3108180005 4395 ACHILLES CORPORATION 100 JP3108000005 5142 ACMOS INC. 100 JP3108100003 6888 ACOM CO.,LTD. 100 JP3108600002 8572 ACRODEA,INC. 100 JP3108120001 3823 ACTCALL INC. 100 JP3108140009 6064 ACTIVIA PROPERTIES INC. 1 JP3047490002 3279 AD-SOL NISSIN CORPORATION 100 JP3122030004 3837 ADASTRIA CO.,LTD. 100 JP3856000009 2685 ADEKA CORPORATION 100 JP3114800000 4401 ADISH CO.,LTD. 100 JP3121500007 7093 ADJUVANT COSME JAPAN CO.,LTD. 100 JP3119620007 4929 ADTEC PLASMA TECHNOLOGY CO.,LTD. 100 JP3122010006 6668 ADVAN CO.,LTD. 100 JP3121950004 7463 ADVANCE CREATE CO.,LTD. 100 JP3122100005 8798 ADVANCE RESIDENCE INVESTMENT CORPORATION 1 JP3047160001 3269 ADVANCED MEDIA,INC. 100 JP3122150000 3773 ADVANEX INC. 100 JP3213400009 5998 ADVANTAGE RISK MANAGEMENT CO.,LTD. 100 JP3122410008 8769 ADVANTEST CORPORATION 100 JP3122400009 6857 ADVENTURE,INC. 100 JP3122380003 6030 ADWAYS INC. 100 JP3121970002 2489 AEON CO.,LTD. 100 JP3388200002 8267 AEON DELIGHT CO.,LTD.
    [Show full text]
  • “Mirai Engineering” a Grand Opportunity for the Future
    “MIRAI ENGINEERING” A GRAND OPPORTUNITY FOR THE FUTURE ANNUAL REPORT FY2016 For the year ended March 31, 2017 CHIYODA CORPORATION ANNUAL REPORT FY2016 PROFILE Chiyoda Corporation is a leading integrated engineering and construction company with a signifi cant INDEX presence in the global oil and gas market, and customers in more than 60 countries. Especially in the fi eld 02 Profile 19 Topics 39 Risk Management of LNG plant engineering and construction, we are a global leader, with a track record of undertaking 03 At a Glance 21 Chiyoda’s ESG Initiatives 41 Corporate Information projects that account for around 40% of the world’s total LNG plant capacity. 05 To Our Shareholders 31 Corporate Governance 43 Stock Information Established in 1948, Chiyoda started with domestic projects in petroleum refining, petrochemicals 11 Financial Highlights 35 Directors & Officers and gas processing. Since the 1970s, Chiyoda has developed a powerful global footprint, taking 13 Business Overview 37 Corporate Governance Dialogue advantage of the many opportunities in the engineering, procurement and construction of energy- related plants, while building a first-class reputation for technological capability, safety and reliability. 2017 During its 70-year history, the Chiyoda Group has been growing steadily under the corporate Order awarded for the pilot plant for production of renewable jet and diesel philosophy of enhancing business by aiming for harmony between energy and the environment, while fuels for euglena Co., Ltd. in Japan contributing to the sustainable development of society. In addition, Chiyoda has expanded business 2003 Order awarded for Sakhalin ll LNG Project into the offshore and upstream sectors, new energy and renewable energies.
    [Show full text]
  • SUMITOMO CHEMICAL COMPANY, LIMITED Notice of the 137 Ordinary General Meeting of Shareholders
    SUMITOMO CHEMICAL COMPANY, LIMITED th Notice of the 137 Ordinary General Meeting of Shareholders THIS DOCUMENT IS A SUMMARY OF A NOTICE AND THE ATTACHMENTS THERETO, THE ORIGINALS OF WHICH ARE IN THE JAPANESE LANGUAGE. THIS DOCUMENT IS MADE ONLY FOR THE REFERENCE PURPOSES OF SHAREHOLDERS WHO LIVE IN COUNTRIES OUTSIDE OF JAPAN AND DOES NOT CONSTITUTE A FORMAL TRANSLATION OF THE ORIGINAL NOTICE AND THE ATTACHMENTS. IN THIS SUMMARY, CERTAIN INFORMATION IS INTENTIONALLY OMITTED. THE ORIGINALS CONTAIN MORE INFORMATION, SUCH AS THE REPORTS OF THE ACCOUNTING AUDITORS AND THE BOARD OF CORPORATE AUDITORS, ETC., WHILE SOME SUPPLEMENTAL INFORMATION NOT CONTAINED IN THE ORIGINALS IS ADDITIONALLY GIVEN IN THIS SUMMARY AS FOOTNOTES WITH ASTERISKS. To Our Shareholders: Please take notice that Sumitomo Chemical Company, Limited (the “Company”) has called an Ordinary General Meeting of Shareholders to be held in Tokyo, Japan on June 21, 2018 (the “Meeting”) for the following purposes: MATTERS TO BE REPORTED: No. 1. Reports on the Company’s business report, consolidated financial statements, and the results of both the Accounting Auditor’s and the Board of Corporate Auditors’ audits of the Company’s consolidated financial statements for the 137th fiscal period (from April 1, 2017, to March 31, 2018) (the “137th fiscal period”). No. 2. Reports on the Company’s non-consolidated financial statements for the 137th fiscal period. MATTERS TO BE RESOLVED: No. 1. To make a partial amendment to Articles of Incorporation. No. 2. To elect thirteen Directors. No. 3. To elect one Corporate Auditor. EXPLANATION OF THE SUBJECT MATTERS OF THE MEETING No.
    [Show full text]